223 related articles for article (PubMed ID: 31667176)
1. Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature.
TriviƱo V; Fidalgo O; Juane A; Pombo J; Cordido F
World J Clin Cases; 2019 Oct; 7(20):3259-3265. PubMed ID: 31667176
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: case report and review of literature.
Hands KE; Alvarez A; Bruder JM
Endocr Pract; 2007 Oct; 13(6):642-6. PubMed ID: 17954421
[TBL] [Abstract][Full Text] [Related]
3. Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma.
Sasagawa Y; Tachibana O; Nakagawa A; Koya D; Iizuka H
J Clin Neurosci; 2015 Mar; 22(3):601-3. PubMed ID: 25455737
[TBL] [Abstract][Full Text] [Related]
4. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
Raj R; Elshimy G; Jacob A; Arya PVA; Unnikrishnan DC; Correa R; Myint ZW
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2337-2347. PubMed ID: 34156518
[TBL] [Abstract][Full Text] [Related]
5. Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment.
Barbosa M; Paredes S; Machado MJ; Almeida R; Marques O
Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32554827
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy.
Keane F; Egan AM; Navin P; Brett F; Dennedy MC
Endocrinol Diabetes Metab Case Rep; 2016; 2016():160021. PubMed ID: 27284452
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone-induced partial empty sella clinically mimicking pituitary apoplexy in a woman with a suspected non-secreting macroadenoma.
Foppiani L; Piredda S; Guido R; Spaziante R; Giusti M
J Endocrinol Invest; 2000 Feb; 23(2):118-21. PubMed ID: 10800766
[TBL] [Abstract][Full Text] [Related]
8. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].
Hernandez Morin N; Huet D; Hautecouverture M
Ann Endocrinol (Paris); 2003 Jun; 64(3):227-31. PubMed ID: 12910066
[TBL] [Abstract][Full Text] [Related]
9. Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists.
Sinnadurai M; Cherukuri RK; Moses RG; Nasser E
J Clin Neurosci; 2010 Sep; 17(9):1201-3. PubMed ID: 20605467
[TBL] [Abstract][Full Text] [Related]
10. Sparsely Granulated Corticotroph Pituitary Macroadenoma Presenting With Pituitary Apoplexy Resulting in Remission of Hypercortisolism.
Liu T; Rossiter JP; Houlden RL; Awad S
AACE Clin Case Rep; 2022; 8(4):166-170. PubMed ID: 35959088
[TBL] [Abstract][Full Text] [Related]
11. Acute presentation of a giant intrathyroidal parathyroid adenoma: a case report.
Rutledge S; Harrison M; O'Connell M; O'Dwyer T; Byrne MM
J Med Case Rep; 2016 Oct; 10(1):286. PubMed ID: 27756436
[TBL] [Abstract][Full Text] [Related]
12. Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone.
Masson EA; Atkin SL; Diver M; White MC
Clin Endocrinol (Oxf); 1993 Jan; 38(1):109-10. PubMed ID: 8435878
[TBL] [Abstract][Full Text] [Related]
13. Pituitary Apoplexy Secondary to Gonadotropin-Releasing Hormone Agonist for Breast Cancer.
Mastandrea K; Voica M; Tetlay M; Hasan F
JCEM Case Rep; 2023 May; 1(3):luad069. PubMed ID: 37908581
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.
Omi Y; Horiuchi K; Haniu K; Tokura M; Nagai E; Isozaki O; Nagashima Y; Okamoto T
Endocr J; 2018 Feb; 65(2):245-252. PubMed ID: 29225207
[TBL] [Abstract][Full Text] [Related]
15. Brain and Optic Chiasm Herniation into Sella after Pituitary Tumor Apoplexy.
Pineyro MM; Furtenbach P; Lima R; Wajskopf S; Sgarbi N; Pisabarro R
Front Endocrinol (Lausanne); 2017; 8():192. PubMed ID: 28824551
[TBL] [Abstract][Full Text] [Related]
16. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
17. Gonadotroph adenoma in multiple endocrine neoplasia type 1.
Sztal-Mazer S; Topliss DJ; Simpson RW; Hamblin PS; Rosenfeld JV; McLean CA
Endocr Pract; 2008; 14(5):592-4. PubMed ID: 18753103
[TBL] [Abstract][Full Text] [Related]
18. RECURRENT PITUITARY APOPLEXY IN AN ADENOMA WITH SWITCHING PHENOTYPES.
Brown TV; Cheesman KC; Post KD
AACE Clin Case Rep; 2020; 6(5):e221-e224. PubMed ID: 32984525
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous remission of acromegaly after infarctive apoplexy with a possible relation to MRI and diabetes mellitus.
Cinar N; Metin Y; Dagdelen S; Ziyal MI; Soylemezoglu F; Erbas T
Neuro Endocrinol Lett; 2013; 34(5):339-42. PubMed ID: 23922047
[TBL] [Abstract][Full Text] [Related]
20. Pituitary apoplexy induced by a combined anterior pituitary test: case report and literature review.
Otsuka F; Kageyama J; Ogura T; Makino H
Endocr J; 1998 Jun; 45(3):393-8. PubMed ID: 9790275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]